Cogent Biosciences, Inc. (COGT): Capital Expenditures
$1.55M
Year ended 2025-12-31
$1.70M
Trailing 12 months to 2026-06-30
-39.0%
3-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.55M | +171.2% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | $573.0K | -79.5% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | $2.80M | -59.3% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | $6.86M | +299.2% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $1.72M | n/a | 2024-02-26, From 2021-01-01 |
| No annual figure between 2019-12-31 and 2021-12-31. | |||
| 2019-12-31 | $33.0K | -94.0% | 2021-03-16, From 2019-01-01 |
| 2018-12-31 | $549.0K | -39.8% | 2020-03-26, From 2018-01-01 |
| 2017-12-31 | $912.0K | n/a | 2019-03-28, From 2017-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | 2025-12-31 | $1.55M | +171.2% |
| Praxis Precision Medicines, Inc. (PRAX) | 2025-12-31 | $56.0K | n/a |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $1.10M | +17.6% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $495.0K | -3.1% |
| Janux Therapeutics, Inc. (JANX) | 2025-12-31 | $1.04M | +190.5% |
| Xencor Inc (XNCR) | 2025-12-31 | $3.15M | -48.3% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $954.0K | -3.9% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $211.0K | -90.3% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $214.0K | +375.6% |
Compare COGT, PRAX, BBIO, VRDN side by side · Screen every company in Pharmaceutical Preparations ↗